
Publications
Scientific articles and outputs from PGNM teams and collaborators.
About
PGNM publications reflect the scientific output of the laboratory’s teams and collaborators, spanning fundamental mechanisms, disease models, technologies and translational research.
2024
Mitochondrial disorders are associated with morphological neuromuscular junction defects.,
Neuromuscul Disord 2024 Dec; 45(): 105235.
2024
[Muscle stem cells and metabolism in Duchenne muscular dystrophy, focus on AMPK].,
Med Sci (Paris) 2024 Nov; 40 Hors série n° 1(): 60-63.
2024
Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for In Vivo Mouse Studies.,
J Med Chem 2024 Jul; 67(13): 11296-11325.
2024
The new missense G376V-TDP-43 variant induces late-onset distal myopathy but not amyotrophic lateral sclerosis.,
Brain 2024 May; 147(5): 1768-1783.
2024
LSD1 controls a nuclear checkpoint in Wnt/β-Catenin signaling to regulate muscle stem cell self-renewal.,
Nucleic Acids Res 2024 Apr; 52(7): 3667-3681.
2024
Neurofilaments: Novel findings and future challenges.,
Curr Opin Cell Biol 2024 Apr; 87(): 102326.
2024
Enhanced capacity for CaMKII signaling mitigates calcium release related contractile fatigue with high intensity exercise.,
Biochim Biophys Acta Mol Cell Res 2024 Feb; 1871(2): 119610.
2024
Neuronal Autophagy: Regulations and Implications in Health and Disease.,
Cells 2024 Jan; 13(1): .
2024
Genetic characterization of non-5q proximal spinal muscular atrophy in a French cohort: the place of whole exome sequencing.,
Eur J Hum Genet 2024 Jan; 32(1): 37-43.